SIRT1 and Alzheimer disease: In this study, induction of melatonin-dependent SIRT1 increased the survival of SAMP8 neurons [260], which may have reduced Aβ accumulation and oxidative stress, thus indicating that the SIRT1 pathway may be a possible target for the treatment of AD.